Ertapenem for treatment of osteomyelitis: a case series

Ertapenem for treatment of osteomyelitis: a case series

<p>Abstract</p> <p>Background</p> <p>Ertapenem is a once-daily broad spectrum carbapenem that is increasingly used to treat polymicrobial osteomyelitis due to diabetic foot and traumatic wound infections. However, limited data exists on ertapenem use for osteomyelitis....

Full description

Bibliographic Details
Main Authors:	Johnson Melissa D, Goswami Neela D, Chu Vivian H
Format:	Article
Language:	English
Published:	BMC 2011-11-01
Series:	BMC Research Notes
Online Access:	http://www.biomedcentral.com/1756-0500/4/478

Similar Items

The treatment of diabetic foot infections: focus on ertapenem
by: Michael Edmonds
Published: (2009-11-01)

A Case of Infective Endocarditis Due to Abiotrophia defectiva, and Treatment with Ertapenem
by: Yücel DUMAN, et al.
Published: (2021-12-01)

Ertapenem Resistance of Escherichia coli
by: Marie-Frédérique Lartigue, et al.
Published: (2007-02-01)

Blastomycotic arthritis and osteomyelitis in childhood: a case series
by: Johnson Rachel R, et al.
Published: (2012-07-01)

Physiologically-Based Pharmacokinetic Model for Ertapenem
by: Forbes, Whitney
Published: (2014)

Ertapenem-Induced Encephalopathy in a Patient With Normal Renal Function
by: S. Scott Sutton PharmD, et al.
Published: (2017-01-01)

Ertapenem Articulating Spacer for the Treatment of Polymicrobial Total Knee Arthroplasty Infection
by: Dragan Radoicic, et al.
Published: (2016-01-01)

Orthopedic management of pubic symphysis osteomyelitis: a case series
by: H. T. Shu, et al.
Published: (2021-07-01)

Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem
by: Fausto de Lalla
Published: (2009-10-01)

The Radiation Sterilization of Ertapenem Sodium in the Solid State
by: Karolina Kilińska, et al.
Published: (2019-08-01)

In Vitro Effectiveness of Ertapenem Against Enterobacteriaceae Isolates
by: Abdullah KILIÇ, et al.
Published: (2006-03-01)

Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia
by: Lee C, et al.
Published: (2018-02-01)

Dosing of Ertapenem in an Extreme Obesity: A Case Report of 250 kg Patient
by: Jana Lass, et al.
Published: (2017-01-01)

Pharmacokinetics of Linezolid and Ertapenem in experimental parapneumonic pleural effusion
by: Tsatsakis Aristidis, et al.
Published: (2010-05-01)

PHARMACOECONOMIC ANALYSIS OF TREATMENT OF OUT-OF-HOSPITAL COMPLICATED ABDOMINAL INFECTIONS WITH NEW-GENERATION CARBAPENEM — ERTAPENEM
by: A.S. Kolbin, et al.
Published: (2010-02-01)

PHARMACOECONOMIC ANALYSIS OF TREATMENT OF OUT-OF-HOSPITAL COMPLICATED ABDOMINAL INFECTIONS WITH NEW-GENERATION CARBAPENEM — ERTAPENEM
by: A.S. Kolbin, et al.
Published: (2010-02-01)

Acute hematogenous osteomyelitis in children: a case series
by: Komang Agung Irianto, et al.
Published: (2019-08-01)

Use of Ertapenem as a Marker for Detection of Carbapenem Resistance for Enterobacteriaceae
by: Sarita Mohapatra, et al.
Published: (2020-12-01)

Ceftolozane–tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case series
by: Xing Tan, et al.
Published: (2019-07-01)

Assays for Determination of Ertapenem for Applications in Therapeutic Drug Monitoring, Pharmacokinetics, and Sample Stability
by: Pickering, Matthew K., et al.
Published: (2014)

Malignancy in chronic osteomyelitis of the foot and ankle (case series)
by: Nikolai M. Kliushin, et al.
Published: (2019-12-01)

Influence of ertapenem administration on the incidence of carbapenem-resistant Pseudomonas aeruginosa
by: Ana Lúcia Lei Munhoz Lima, et al.

Prolonged Use of Ertapenem to Treat Infected Diabetic Foot Ulcers
by: Ashwin Algudkar, et al.
Published: (2010-01-01)

Ertapenem susceptibility of extended spectrum <it>beta</it>-lactamase-producing organisms
by: Selby Edward B, et al.
Published: (2007-06-01)

Successful Use of Ertapenem for the Treatment of Enterobacter cloacae Complex Infection of the Central Nervous System (CNS)
by: Sunish Shah, et al.
Published: (2019-01-01)

Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution
by: Ximena Gonzalo, et al.
Published: (2020-08-01)

Surgical Treatment of Chronic Osteomyelitis
by: M. R. Garaev, et al.
Published: (2019-11-01)

Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials
by: Liu Ping, et al.
Published: (2009-12-01)

Multiple Pyogenic Liver Abscesses Caused by Eggerthella lenta Treated with Ertapenem: A Case Report
by: Richard M. Elias, et al.
Published: (2012-01-01)

Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study
by: Ortiz-Álvarez A, et al.
Published: (2018-12-01)

Osteomyelitis of the Knee Following Intra-Articular Injections: A Case Series
by: Anand Sobhraj Devnani, et al.
Published: (2020-03-01)

Validated HPLC-UV and LC-MS Assays for Therapeutic Drug Monitoring of Ertapenem in Human Plasma
by: Pickering, M., et al.
Published: (2012)

Case series of carbapenemase-producing Enterobacteriaceae osteomyelitis: Feel it in your bones
by: B. Davido, et al.
Published: (2020-12-01)

Recommendations for the treatment of osteomyelitis
by: Ana Lucia L. Lima, et al.
Published: (2014-09-01)

Investigation of optimal dosing strategies for Ertapenem for varying BMI using mathematical modeling
by: Jewett, Bethany
Published: (2019)

The Clinical Efficacy and Safety of Ertapenem for the Treatment of Complicated Urinary Tract Infections Caused by ESBL-Producing Bacteria in Children
by: Ayse Karaaslan, et al.
Published: (2015-01-01)

Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
by: Jocelyn Teo, et al.
Published: (2012-01-01)

A Case of Acute Osteomyelitis: An Update on Diagnosis and Treatment
by: Elena Chiappini, et al.
Published: (2016-05-01)

Add-On Therapy with Ertapenem in Infections with Multidrug Resistant Gram-Negative Bacteria: Pediatric Experience
by: Sevgen Tanır Basaranoglu, et al.
Published: (2017-01-01)

Clinical features and risk factors of infections caused by Klebsiella pneumoniae with heteroresistance to cefepime and ertapenem
by: DAI Jialing, et al.
Published: (2019-02-01)